Global Circulating Tumor Cells Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

Growing prevalence of cancer has heightened the need for effective and early diagnosis. Circulating tumor cells cater to this heightened need and are therefore, expected to witness a surge in demand during the forecast period. Majority of cancer deaths are due to circulating tumor cells and an early diagnosis of the same is expected to increase survival rates. Targeted therapy in cancer has large untapped opportunities and therefore, entails extensive R&D investments aimed at new product development. However, high procedure costs and lack of commercialized products are expected to impede market growth during the forecast period.

Further key findings from the study suggest:

  • Application of alterations in the expression profiles of EMT-associated transcriptional regulators and their molecular targets as biomarkers in EMT study is expected to serve as an impetus for diagnosis of tumor
  • North America led the CTC market in 2018 due to rising cases of cancer, oncology research funding, and favorable government initiatives for clinical diagnostic products
  • APAC is anticipated to witness the highest CAGR of over 16% from 2019 to 2025 due to infrastructural development in care centers and increased sales of CTC diagnostic tests
  • Rising need for new diagnosis methods for cancer has encouraged R&D in developing economies of APAC. This will help expand the region further
  • Fluxion Biosciences, Inc.; AdnaGen AG; Biocept, Inc.; Ikonisys, Inc.; and Sysmex Corp. are some of the key industry participants
  • Key companies focus on the development of novel technologies for CTC enrichment & detection through collaborations with hospitals and university-based research institutes to gain access to target population

Segmentation:

Technology Outlook

    • CTC Enrichment Methods

      • Ex vivo Positive Selection

      • In vivo Positive Selection

      • Negative Selection

      • Microchips

      • Single Spiral Microchannel

    • CTC Detection Methods

      • Immunocytochemical Technologies

      • Molecular (RNA)-based Technologies

      • Functional in vitro Cell Invasion Assay

      • Xenotransplantation Models

    • CTC Analysis

  • Application Outlook

    • Cancer Stem Cell Research

    • EMT Biomarkers Development

    • Tumorgenesis Research

    • Other Applications

  • Regional Outlook

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • Spain

      • France

      • Italy

      • Russia

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Singapore

      • Australia

    • Latin America

      • Brazil

      • Argentina

    • MEA

      • South Africa

      • UAE

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Circulating Tumor Cells Market, By Technology

7.1.  Circulating Tumor Cells Market, by Technology, 2020-2030

7.1.1.    CTC Detection & Enrichment Methods

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    CTC Direct Detection Methods

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    CTC Analysis

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Circulating Tumor Cells Market, By Application

8.1.  Circulating Tumor Cells Market, by Application, 2020-2030

8.1.1.    Clinical/ Liquid Biopsy

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Research

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Circulating Tumor Cells Market, By Product

9.1.  Circulating Tumor Cells Market, by Product, 2020-2030

9.1.1.    Kits & Reagents

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Blood Collection Tubes

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Devices or Systems

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Circulating Tumor Cells Market, By Specimen

10.1.        Circulating Tumor Cells Market, by Specimen, 2020-2030

10.1.1.  Blood

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Bone Marrow

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Other Body Fluids

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Circulating Tumor Cells Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.1.2.  Market Revenue and Forecast, by Application (2016-2030)

11.1.3.  Market Revenue and Forecast, by Product (2016-2030)

11.1.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.2.2.  Market Revenue and Forecast, by Application (2016-2030)

11.2.3.  Market Revenue and Forecast, by Product (2016-2030)

11.2.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.3.2.  Market Revenue and Forecast, by Application (2016-2030)

11.3.3.  Market Revenue and Forecast, by Product (2016-2030)

11.3.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.4.2.  Market Revenue and Forecast, by Application (2016-2030)

11.4.3.  Market Revenue and Forecast, by Product (2016-2030)

11.4.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.5.2.  Market Revenue and Forecast, by Application (2016-2030)

11.5.3.  Market Revenue and Forecast, by Product (2016-2030)

11.5.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

Chapter 12.  Company Profiles

12.1.              QIAGEN

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Bio-Techne Corporation

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Precision for Medicine

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              AVIVA Biosciences

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              BIOCEPT, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              BioCEP Ltd.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Fluxion Biosciences, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Greiner Bio One International GmbH

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Ikonisys Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Miltenyi Biotec

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           IVDiagnostics

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           BioFluidica

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Canopus Bioscience Ltd.

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           Biolidics Limited

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

12.15.           Creativ MicroTech, Inc.

12.15.1.               Company Overview

12.15.2.               Product Offerings

12.15.3.               Financial Performance

12.15.4.               Recent Initiatives

12.16.           LungLife AI, Inc.

12.16.1.               Company Overview

12.16.2.               Product Offerings

12.16.3.               Financial Performance

12.16.4.               Recent Initiatives

12.17.           Epic Sciences

12.17.1.               Company Overview

12.17.2.               Product Offerings

12.17.3.               Financial Performance

12.17.4.               Recent Initiatives

12.18.           Rarecells Diagnostics

12.18.1.               Company Overview

12.18.2.               Product Offerings

12.18.3.               Financial Performance

12.18.4.               Recent Initiatives

12.19.           ScreenCell

12.19.1.               Company Overview

12.19.2.               Product Offerings

12.19.3.               Financial Performance

12.19.4.               Recent Initiatives

12.20.           Menarini Silicon Biosystems

12.20.1.               Company Overview

12.20.2.               Product Offerings

12.20.3.               Financial Performance

12.20.4.               Recent Initiatives

12.21.           LineaRx, Inc. (Vitatex, Inc.)

12.21.1.               Company Overview

12.21.2.               Product Offerings

12.21.3.               Financial Performance

12.21.4.               Recent Initiatives

12.22.           Sysmex Corporation

12.22.1.               Company Overview

12.22.2.               Product Offerings

12.22.3.               Financial Performance

12.22.4.               Recent Initiatives

12.23.           STEMCELL Technologies, Inc.

12.23.1.               Company Overview

12.23.2.               Product Offerings

12.23.3.               Financial Performance

12.23.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers